Cas:94527-39-6 1-Bromo-4-methoxy-2-(methoxymethyl)benzene manufacturer & supplier

We serve Chemical Name:1-Bromo-4-methoxy-2-(methoxymethyl)benzene CAS:94527-39-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Bromo-4-methoxy-2-(methoxymethyl)benzene

Chemical Name:1-Bromo-4-methoxy-2-(methoxymethyl)benzene
CAS.NO:94527-39-6
Synonyms:1-Bromo-4-methoxy-2-(methoxymethyl)benzene;Benzene, 1-bromo-4-methoxy-2-(methoxymethyl)-
Molecular Formula:C9H11BrO2
Molecular Weight:231.086
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:261.7±25.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.527
PSA:18.46000
Exact Mass:229.994232
LogP:2.90

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Bromo-4-methoxy-2-(methoxymethyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzene, 1-bromo-4-methoxy-2-(methoxymethyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzene, 1-bromo-4-methoxy-2-(methoxymethyl)- Use and application,Benzene, 1-bromo-4-methoxy-2-(methoxymethyl)- technical grade,usp/ep/jp grade.


Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. 1-Bromo-4-methoxy-2-(methoxymethyl)benzene manufacturer The Company��s immuno-oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). 1-Bromo-4-methoxy-2-(methoxymethyl)benzene supplier Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday. 1-Bromo-4-methoxy-2-(methoxymethyl)benzene vendor The ban will be in place for up to 14 days, and is aimed at helping contain the spread of the Wuhan coronavirus. So far, there have been no confirmed coronavirus cases in New Zealand or any South Pacific island. 1-Bromo-4-methoxy-2-(methoxymethyl)benzene factory We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries.